Brief: Lundbeck Announces Advancement Of Lu AG09222 Clinical Development

H Lundbeck A/S

15/03/2024 08:05

March 15 (Reuters) - H Lundbeck A/S  HLUNb.CO :
    * LUNDBECK'S POTENTIAL FIRST-IN-CLASS THERAPY FOR MIGRAINE
PREVENTION ENTERS ADVANCED CLINICAL STAGE
    * LU AG09222 MAY OFFER A POTENTIAL TREATMENT OPTION IN A NEW
TREATMENT CLASS FOR PEOPLE WITH MIGRAINE

Source text for Eikon:  ID:nWkr1ShPjq 
Further company coverage:  HLUNb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))